User profiles for V. Herasevich

Vitaly Herasevich, MD, PhD, FCCM, FAMIA

Professor of Anesthesiology and Medicine, Mayo Clinic
Verified email at mayo.edu
Cited by 7428

An appraisal of published usability evaluations of electronic health records via systematic review

…, AM Farrell, J Zhang, V Herasevich - Journal of the …, 2017 - academic.oup.com
Objective: In this systematic review, we aimed to evaluate methodological and reporting
trends present in the current literature by investigating published usability studies of electronic …

Clinical characteristics, treatment, and outcomes of critically ill patients with COVID-19: a scoping review

C Huang, J Soleimani, S Herasevich, Y Pinevich… - Mayo Clinic …, 2021 - Elsevier
A growing number of studies on coronavirus disease 2019 (COVID-19) are becoming
available, but a synthesis of available data focusing on the critically ill population has not been …

Tele-critical care: an update from the society of critical care medicine tele-ICU committee

…, FA Winterbottom, V Herasevich - Critical care …, 2020 - journals.lww.com
Objectives: In 2014, the Tele-ICU Committee of the Society of Critical Care Medicine
published an article regarding the state of ICU telemedicine, one better defined today as tele-critical …

[HTML][HTML] Early safety indicators of COVID-19 convalescent plasma in 5000 patients

…, MR Buras, MNP Vogt, V Herasevich… - The Journal of …, 2020 - Am Soc Clin Investig
BACKGROUND Convalescent plasma is the only antibody-based therapy currently available
for patients with coronavirus disease 2019 (COVID-19). It has robust historical precedence …

Safety update: COVID-19 convalescent plasma in 20,000 hospitalized patients

…, MR Buras, MNP Vogt, V Herasevich… - Mayo Clinic …, 2020 - Elsevier
Objective To provide an update on key safety metrics after transfusion of convalescent plasma
in hospitalized coronavirus 2019 (COVID-19) patients, having previously demonstrated …

[HTML][HTML] Convalescent plasma antibody levels and the risk of death from Covid-19

…, RF Rea, DO Hodge, V Herasevich… - … England Journal of …, 2021 - Mass Medical Soc
Background Convalescent plasma has been widely used to treat coronavirus disease 2019 (Covid-19)
under the presumption that such plasma contains potentially therapeutic …

Clinical spectrum, frequency, and significance of myocardial dysfunction in severe sepsis and septic shock

…, M Masaki, T Yuasa, S Gillespie, V Herasevich… - Mayo Clinic …, 2012 - Elsevier
Objective To determine the frequency and spectrum of myocardial dysfunction in patients with
severe sepsis and septic shock using transthoracic echocardiography and to evaluate the …

Informatics infrastructure for syndrome surveillance, decision support, reporting, and modeling of critical illness

V Herasevich, BW Pickering, Y Dong, SG Peters… - Mayo Clinic …, 2010 - Elsevier
OBJECTIVE To develop and validate an informatics infrastructure for syndrome surveillance,
decision support, reporting, and modeling of critical illness. METHODS Using open-schema …

The effect of two different electronic health record user interfaces on intensive care provider task load, errors of cognition, and performance

A Ahmed, S Chandra, V Herasevich, O Gajic… - Critical care …, 2011 - journals.lww.com
Objectives: The care of critically ill patients generates large quantities of data. Increasingly,
these data are presented to the provider within an electronic medical record. The manner in …

Evaluating muscle mass by using markers of kidney function: development of the sarcopenia index

…, L Kukrálová, K Sarvottam, V Herasevich… - Critical care …, 2017 - journals.lww.com
Objectives: Sarcopenia is associated with a poor prognosis in the ICU. The purpose of this
study was to describe a simple sarcopenia index using routinely available renal biomarkers …